EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Niclosamide potentiates TMEM16A and induces vasoconstriction

Pengfei Liang iD, Yui Chun S Wan iD, Kuai Yu iD, H Criss Hartzell iD, Huanghe Yang iD

Journal of General Physiology · 2024

DOI: 10.1085/jgp.202313460 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of General Physiology, 2024. Verfasst von Pengfei Liang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Duke University School of Medicine, Durham, NC, USA. Hauptthemen laut MEDLINE: Niclosamide, Anoctamin-1, Vasoconstriction. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0). Gefördert von: NIGMS NIH HHS, NIH HHS, American Heart Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The TMEM16A calcium-activated chloride channel is a promising therapeutic target for various diseases. Niclosamide, an anthelmintic medication, has been considered a TMEM16A inhibitor for treating asthma and chronic obstructive pulmonary disease (COPD) but was recently found to possess broad-spectrum off-target effects. Here, we show that, under physiological Ca2+ (200–500 nM) and voltages, niclosamide acutely potentiates TMEM16A. Our computational and functional characterizations pinpoint a putative niclosamide binding site on the extracellular side of TMEM16A. Mutations in this site attenuate the potentiation. Moreover, niclosamide potentiates endogenous TMEM16A in vascular smooth muscle cells, triggers intracellular calcium increase, and constricts the murine mesenteric artery. Our findings advise caution when considering clinical applications of niclosamide as a TMEM16A inhibitor. The identification of the putative niclosamide binding site provides insights into the mechanism of TMEM16A pharmacological modulation and provides insights into developing specific TMEM16A modulators to treat human diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NiclosamideAnoctamin-1VasoconstrictionAnimalsMiceHumansHEK293 CellsBinding SitesCalciumMesenteric ArteriesMuscle, Smooth, VascularMyocytes, Smooth MuscleMale

Substanzen

NiclosamideAnoctamin-1ANO1 protein, mouseCalcium

Autor:innen und Institutionen

  • Department of Biochemistry, Duke University School of Medicine, Durham, NC, USA.
  • Department of Cell Biology, Emory University School of Medicine, Atlanta, GA, USA.
  • Department of Neurobiology, Duke University School of Medicine, Durham, NC, USA.

ORCID-Profile: Pengfei Liang, Yui Chun S Wan, Kuai Yu, H Criss Hartzell, Huanghe Yang

Förderung

  • NIGMS NIH HHS
  • NIH HHS
  • American Heart Association
  • National Institute of General Medical Sciences
  • National Institutes of Health

Zitieren

APA

Liang, P., Wan, Y. C. S., Yu, K., Hartzell, H. C., & Yang, H. (2024). Niclosamide potentiates TMEM16A and induces vasoconstriction. Journal of General Physiology. https://doi.org/10.1085/jgp.202313460

Vancouver

Liang P, Wan YCS, Yu K, Hartzell HC, Yang H. Niclosamide potentiates TMEM16A and induces vasoconstriction. Journal of General Physiology. 2024. doi:10.1085/jgp.202313460

BibTeX
@article{Liang2024,
  author = {Liang, Pengfei and Wan, Yui Chun S and Yu, Kuai and Hartzell, H Criss and Yang, Huanghe},
  title = {Niclosamide potentiates TMEM16A and induces vasoconstriction},
  journal = {Journal of General Physiology},
  year = {2024},
  doi = {10.1085/jgp.202313460}
}
Kostenlos starten →